{"id":"tretinoin-gel-tretinoin","safety":{"commonSideEffects":[{"rate":"40-60","effect":"Erythema and irritation"},{"rate":"40-50","effect":"Peeling and dryness"},{"rate":"null","effect":"Photosensitivity"},{"rate":"20-40","effect":"Burning or stinging"},{"rate":"null","effect":"Retinization (initial worsening of acne)"}]},"_chembl":{"chemblId":"CHEMBL2218871","moleculeType":"Small molecule","molecularWeight":"713.14"},"_dailymed":{"setId":"1f772408-52a3-45b2-b053-8fc78948983c","title":"CLINDAMYCIN PHOSPHATE AND TRETINOIN GEL 1.2%/0.025% GEL [ENCUBE ETHICALS, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tretinoin acts as a ligand for nuclear retinoic acid receptors (RAR-α, RAR-β, RAR-γ), which regulate gene expression involved in cell differentiation and proliferation. By increasing epidermal cell turnover and reducing comedone formation, it addresses the pathogenic mechanisms of acne. It also stimulates collagen production and reduces fine wrinkles, making it effective for photoaging.","oneSentence":"Tretinoin is a vitamin A derivative that binds to retinoic acid receptors in skin cells to promote cell turnover, reduce sebum production, and normalize keratinization.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:40:00.197Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris"},{"name":"Photoaging and fine wrinkles"},{"name":"Acute promyelocytic leukemia (systemic formulation)"}]},"trialDetails":[{"nctId":"NCT07469228","phase":"PHASE1","title":"A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2025-08-04","conditions":"Acne Vulgaris","enrollment":1043},{"nctId":"NCT07345507","phase":"NA","title":"Comparison of Efficacy of Metformin Gel 30% vs Triple Combination Cream (Hydroquinone 4%, Flucinolone Acetonide 0.01%, Tretinoin 0.025%) in Treatment of Melasma in Tertiary Care Hospital Karachi","status":"COMPLETED","sponsor":"Jinnah Postgraduate Medical Centre","startDate":"2025-02-01","conditions":"Melasma","enrollment":34},{"nctId":"NCT06685328","phase":"NA","title":"Minimal Vitrectomy and ILM Flap with Sodium Hyaluronate Gel for MH","status":"ENROLLING_BY_INVITATION","sponsor":"Jie Zhong","startDate":"2024-11-01","conditions":"Macular Hole, Macular Hole Surgery, Idiopathic Macular Hole","enrollment":52},{"nctId":"NCT04548349","phase":"PHASE4","title":"Profiling the Skin Microbiome in Response to Altreno in Acne Patients","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2021-04-23","conditions":"Acne, Healthy","enrollment":25},{"nctId":"NCT00647556","phase":"PHASE3","title":"Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-04","conditions":"Photoaging","enrollment":30},{"nctId":"NCT01522456","phase":"PHASE4","title":"Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2012-04","conditions":"Acne Vulgaris","enrollment":73},{"nctId":"NCT04883736","phase":"EARLY_PHASE1","title":"A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2020-08-31","conditions":"Acne Vulgaris","enrollment":973},{"nctId":"NCT02249767","phase":"PHASE3","title":"Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel","status":"COMPLETED","sponsor":"Spear Pharmaceuticals","startDate":"2013-11","conditions":"Acne","enrollment":574},{"nctId":"NCT01243450","phase":"PHASE3","title":"Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo","status":"COMPLETED","sponsor":"Spear Pharmaceuticals","startDate":"2009-10","conditions":"Acne","enrollment":958},{"nctId":"NCT04206631","phase":"PHASE1","title":"Comedone Extraction and Oral Doxycycline In The First Line Treatment of Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2015-04-01","conditions":"Acne Vulgaris","enrollment":140},{"nctId":"NCT02731105","phase":"PHASE4","title":"Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products","status":"COMPLETED","sponsor":"GWT-TUD GmbH","startDate":"2015-02","conditions":"Acne Vulgaris","enrollment":22},{"nctId":"NCT01047189","phase":"PHASE4","title":"Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2009-03","conditions":"Acne Vulgaris","enrollment":26},{"nctId":"NCT01929278","phase":"PHASE1","title":"W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-12-08","conditions":"Acne Vulgaris","enrollment":37},{"nctId":"NCT01915758","phase":"PHASE1","title":"W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-11-21","conditions":"Acne Vulgaris","enrollment":64},{"nctId":"NCT00689117","phase":"PHASE3","title":"A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-04","conditions":"Acne Vulgaris, Acne","enrollment":1649},{"nctId":"NCT00841776","phase":"PHASE4","title":"Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2007-08","conditions":"Acne","enrollment":54},{"nctId":"NCT00891982","phase":"PHASE3","title":"A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-04-01","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT01406080","phase":"PHASE3","title":"A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging","status":"COMPLETED","sponsor":"Galderma Brasil Ltda.","startDate":"2013-01","conditions":"Photoaging, Photodamage","enrollment":128},{"nctId":"NCT00939133","phase":"PHASE4","title":"Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin","status":"COMPLETED","sponsor":"Dermatrials Research","startDate":"2009-07","conditions":"Acne","enrollment":20},{"nctId":"NCT01135069","phase":"PHASE3","title":"Bioequivalence Study of Generic Tretinoin 0.1% Microsphere Gel, 0.1% Retin-A Micro® and Placebo","status":"COMPLETED","sponsor":"Spear Pharmaceuticals","startDate":"2009-10","conditions":"Acne","enrollment":480},{"nctId":"NCT01125930","phase":"PHASE3","title":"Atralin Gel for the Treatment of Rosacea","status":"TERMINATED","sponsor":"Lisa E. Maier","startDate":"2010-05","conditions":"Rosacea","enrollment":68},{"nctId":"NCT00823901","phase":"PHASE2, PHASE3","title":"Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-02","conditions":"Rosacea","enrollment":83},{"nctId":"NCT00919191","phase":"PHASE4","title":"Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2009-04","conditions":"Acne Vulgaris","enrollment":26},{"nctId":"NCT01313728","phase":"PHASE4","title":"A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2010-12","conditions":"Acne Vulgaris","enrollment":26},{"nctId":"NCT00952523","phase":"PHASE4","title":"Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2009-07","conditions":"Acne Vulgaris","enrollment":162},{"nctId":"NCT00714714","phase":"PHASE4","title":"Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2008-01","conditions":"Acne Vulgaris","enrollment":25},{"nctId":"NCT00907257","phase":"PHASE4","title":"A Study of Different Use Regimens Using Two Acne Treatments","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2009-02","conditions":"Acne Vulgaris","enrollment":247},{"nctId":"NCT00907335","phase":"PHASE2","title":"A Study of Acne Treatment in Children Ages 9 to 11","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2009-02","conditions":"Acne Vulgaris","enrollment":110},{"nctId":"NCT01206348","phase":"PHASE4","title":"Combination Treatment for Moderate to Severe Acne","status":"COMPLETED","sponsor":"Medicis Global Service Corporation","startDate":"2010-09","conditions":"Acne","enrollment":97},{"nctId":"NCT00835198","phase":"PHASE4","title":"Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Allergan","startDate":"2008-12","conditions":"Acne Vulgaris","enrollment":163},{"nctId":"NCT01448733","phase":"PHASE4","title":"Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris","status":"UNKNOWN","sponsor":"Zeichner, Joshua, M.D.","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT01422785","phase":"PHASE4","title":"A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne","status":"UNKNOWN","sponsor":"Zeichner, Joshua, M.D.","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT01257906","phase":"NA","title":"Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo","status":"COMPLETED","sponsor":"Actavis Mid-Atlantic LLC","startDate":"2010-05","conditions":"MILD TO SEVERE ACNE VULGARIS","enrollment":1225},{"nctId":"NCT00838812","phase":"PHASE3","title":"Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate","status":"COMPLETED","sponsor":"Igefarma Laboratorios S.A.","startDate":"2009-03","conditions":"Acne Vulgaris","enrollment":154},{"nctId":"NCT01111994","phase":"PHASE4","title":"Efficacy & Safety of Clindamycin and Tretinoin in Acne","status":"UNKNOWN","sponsor":"Callender Center for Clinical Research","startDate":"2009-11","conditions":"Acne","enrollment":30},{"nctId":"NCT00176527","phase":"PHASE2","title":"Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy","status":"TERMINATED","sponsor":"University of Medicine and Dentistry of New Jersey","startDate":"2002-11","conditions":"Prostate Cancer","enrollment":40},{"nctId":"NCT00621218","phase":"PHASE2","title":"A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea","status":"COMPLETED","sponsor":"Coria Laboratories, Ltd.","startDate":"2008-02","conditions":"Rosacea","enrollment":36},{"nctId":"NCT00603772","phase":"PHASE1","title":"Clinical Evaluation of the Photoallergy Potential of Atralin Gel","status":"COMPLETED","sponsor":"Coria Laboratories, Ltd.","startDate":"2008-01","conditions":"Healthy","enrollment":40},{"nctId":"NCT00604032","phase":"PHASE1","title":"Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%","status":"COMPLETED","sponsor":"Coria Laboratories, Ltd.","startDate":"2008-01","conditions":"Healthy","enrollment":60},{"nctId":"NCT00002439","phase":"NA","title":"A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma","status":"COMPLETED","sponsor":"Anderson Clinical Research","startDate":"","conditions":"Sarcoma, Kaposi, HIV Infections","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":257,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Tretinoin Gel (tretinoin)","genericName":"Tretinoin Gel (tretinoin)","companyName":"Stiefel, a GSK Company","companyId":"stiefel-a-gsk-company","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tretinoin is a vitamin A derivative that binds to retinoic acid receptors in skin cells to promote cell turnover, reduce sebum production, and normalize keratinization. Used for Acne vulgaris, Photoaging and fine wrinkles, Acute promyelocytic leukemia (systemic formulation).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}